Inotiv, Inc.
A CRO providing nonclinical drug development services and research models.
NOTV | US
Overview
Corporate Details
- ISIN(s):
- US09058M1036 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 2701 KENT AVE, WEST LAFAYETTE
- Website:
- https://www.inotiv.com/
Description
Inotiv, Inc. is a contract research organization (CRO) providing a comprehensive range of nonclinical and analytical drug discovery and development services. Key service areas include general toxicology, pathology, histology, drug metabolism and pharmacokinetics (DMPK), and bioanalytical solutions. The company also offers specialized services such as digital pathology with AI-driven image analysis, monoclonal antibody production, and developmental and reproductive toxicology (DART) studies. In addition to its CRO services, Inotiv is a major provider of research models and related products. This includes a wide array of animal models, genetically engineered model services (GEMS), contract breeding, surgical services, and Teklad laboratory animal diets and bedding. Inotiv serves clients across the pharmaceutical, biotechnology, medical device, academic, and government sectors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-04 17:15 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.6 KB | ||
| 2025-02-04 17:14 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 6.8 KB | ||
| 2025-02-04 17:13 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 6.9 KB | ||
| 2025-02-04 17:12 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.4 KB | ||
| 2025-01-22 19:24 |
DEF 14A
|
English | 5.0 MB | ||
| 2025-01-22 19:15 |
DEFA14A
|
English | 485.1 KB | ||
| 2025-01-22 19:03 |
ARS
|
English | 19.9 MB | ||
| 2025-01-10 17:01 |
424B7
|
English | 95.6 KB | ||
| 2024-12-23 22:47 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 6.5 KB | ||
| 2024-12-18 17:06 |
8-K
|
English | 288.9 KB | ||
| 2024-12-18 17:05 |
424B5
|
English | 248.8 KB | ||
| 2024-12-17 17:01 |
424B5
|
English | 248.3 KB | ||
| 2024-12-12 19:46 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 6.7 KB | ||
| 2024-12-10 17:13 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 6.7 KB | ||
| 2024-12-10 09:34 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 6.6 KB |
Automate Your Workflow. Get a real-time feed of all Inotiv, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inotiv, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inotiv, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
